Regulation of phosphatidylinositol 3-kinase by polyisoprenyl phosphates in neutrophil-mediated tissue injury

Caroline Bonnans, Koichi Fukunaga, Raquel Keledjian, Nicos A. Petasis, Bruce D. Levy

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Neutrophils play a central role in host defense, inflammation, and tissue injury. Recent findings indicate a novel role for polyisoprenyl phosphates (PIPPs) as natural down-regulatory signals in neutrophils. The relationship between PIPPs and neutrophil early activating signals, such as phosphoinositides, has not been previously determined. Here, we establish presqualene diphosphate (PSDP) as an endogenous PIPP regulator of phosphatidylinositol 3-kinase (PI3K). In human neutrophils, leukotriene B 4 (LTB 4) triggered rapid decreases in PSDP and reciprocal increases in PI3K activity. In addition, PSDP was identified by gas chromatography/mass spectrometry in p110γ-PI3K immunoprecipitates obtained 30 s after LTB 4, indicating a physical interaction between PSDP and PI3K in activated neutrophils. Moreover, PSDP (0.4-800 pmol) directly inhibited recombinant human p110γ-PI3K activity. During an experimental model of lung injury and inflammation, a reciprocal relationship was also present in vivo for lung PSDP and PI3K activity. To investigate its therapeutic potential, we developed a new PSDP structural mimetic that blocked human neutrophil activation and mouse lung PI3K activity and inflammation. Together, our findings indicate that PSDP is an endogenous PI3K inhibitor, and suggest that in inflammatory diseases characterized by excessive neutrophil activation, PIPPs can serve as structural templates in a novel antineutrophil therapeutic strategy to limit tissue injury.

Original languageEnglish
Pages (from-to)857-863
Number of pages7
JournalJournal of Experimental Medicine
Volume203
Issue number4
DOIs
Publication statusPublished - 2006 Apr 17
Externally publishedYes

Fingerprint

Polyisoprenyl Phosphates
Phosphatidylinositol 3-Kinase
Neutrophils
Wounds and Injuries
Neutrophil Activation
Leukotriene B4
Inflammation
Lung
presqualene pyrophosphate
Lung Injury
Phosphatidylinositols
Gas Chromatography-Mass Spectrometry
Pneumonia
Theoretical Models

ASJC Scopus subject areas

  • Immunology

Cite this

Regulation of phosphatidylinositol 3-kinase by polyisoprenyl phosphates in neutrophil-mediated tissue injury. / Bonnans, Caroline; Fukunaga, Koichi; Keledjian, Raquel; Petasis, Nicos A.; Levy, Bruce D.

In: Journal of Experimental Medicine, Vol. 203, No. 4, 17.04.2006, p. 857-863.

Research output: Contribution to journalArticle

Bonnans, Caroline ; Fukunaga, Koichi ; Keledjian, Raquel ; Petasis, Nicos A. ; Levy, Bruce D. / Regulation of phosphatidylinositol 3-kinase by polyisoprenyl phosphates in neutrophil-mediated tissue injury. In: Journal of Experimental Medicine. 2006 ; Vol. 203, No. 4. pp. 857-863.
@article{48def04c12d1466d812ca8cf97bfbbb5,
title = "Regulation of phosphatidylinositol 3-kinase by polyisoprenyl phosphates in neutrophil-mediated tissue injury",
abstract = "Neutrophils play a central role in host defense, inflammation, and tissue injury. Recent findings indicate a novel role for polyisoprenyl phosphates (PIPPs) as natural down-regulatory signals in neutrophils. The relationship between PIPPs and neutrophil early activating signals, such as phosphoinositides, has not been previously determined. Here, we establish presqualene diphosphate (PSDP) as an endogenous PIPP regulator of phosphatidylinositol 3-kinase (PI3K). In human neutrophils, leukotriene B 4 (LTB 4) triggered rapid decreases in PSDP and reciprocal increases in PI3K activity. In addition, PSDP was identified by gas chromatography/mass spectrometry in p110γ-PI3K immunoprecipitates obtained 30 s after LTB 4, indicating a physical interaction between PSDP and PI3K in activated neutrophils. Moreover, PSDP (0.4-800 pmol) directly inhibited recombinant human p110γ-PI3K activity. During an experimental model of lung injury and inflammation, a reciprocal relationship was also present in vivo for lung PSDP and PI3K activity. To investigate its therapeutic potential, we developed a new PSDP structural mimetic that blocked human neutrophil activation and mouse lung PI3K activity and inflammation. Together, our findings indicate that PSDP is an endogenous PI3K inhibitor, and suggest that in inflammatory diseases characterized by excessive neutrophil activation, PIPPs can serve as structural templates in a novel antineutrophil therapeutic strategy to limit tissue injury.",
author = "Caroline Bonnans and Koichi Fukunaga and Raquel Keledjian and Petasis, {Nicos A.} and Levy, {Bruce D.}",
year = "2006",
month = "4",
day = "17",
doi = "10.1084/jem.20052143",
language = "English",
volume = "203",
pages = "857--863",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "4",

}

TY - JOUR

T1 - Regulation of phosphatidylinositol 3-kinase by polyisoprenyl phosphates in neutrophil-mediated tissue injury

AU - Bonnans, Caroline

AU - Fukunaga, Koichi

AU - Keledjian, Raquel

AU - Petasis, Nicos A.

AU - Levy, Bruce D.

PY - 2006/4/17

Y1 - 2006/4/17

N2 - Neutrophils play a central role in host defense, inflammation, and tissue injury. Recent findings indicate a novel role for polyisoprenyl phosphates (PIPPs) as natural down-regulatory signals in neutrophils. The relationship between PIPPs and neutrophil early activating signals, such as phosphoinositides, has not been previously determined. Here, we establish presqualene diphosphate (PSDP) as an endogenous PIPP regulator of phosphatidylinositol 3-kinase (PI3K). In human neutrophils, leukotriene B 4 (LTB 4) triggered rapid decreases in PSDP and reciprocal increases in PI3K activity. In addition, PSDP was identified by gas chromatography/mass spectrometry in p110γ-PI3K immunoprecipitates obtained 30 s after LTB 4, indicating a physical interaction between PSDP and PI3K in activated neutrophils. Moreover, PSDP (0.4-800 pmol) directly inhibited recombinant human p110γ-PI3K activity. During an experimental model of lung injury and inflammation, a reciprocal relationship was also present in vivo for lung PSDP and PI3K activity. To investigate its therapeutic potential, we developed a new PSDP structural mimetic that blocked human neutrophil activation and mouse lung PI3K activity and inflammation. Together, our findings indicate that PSDP is an endogenous PI3K inhibitor, and suggest that in inflammatory diseases characterized by excessive neutrophil activation, PIPPs can serve as structural templates in a novel antineutrophil therapeutic strategy to limit tissue injury.

AB - Neutrophils play a central role in host defense, inflammation, and tissue injury. Recent findings indicate a novel role for polyisoprenyl phosphates (PIPPs) as natural down-regulatory signals in neutrophils. The relationship between PIPPs and neutrophil early activating signals, such as phosphoinositides, has not been previously determined. Here, we establish presqualene diphosphate (PSDP) as an endogenous PIPP regulator of phosphatidylinositol 3-kinase (PI3K). In human neutrophils, leukotriene B 4 (LTB 4) triggered rapid decreases in PSDP and reciprocal increases in PI3K activity. In addition, PSDP was identified by gas chromatography/mass spectrometry in p110γ-PI3K immunoprecipitates obtained 30 s after LTB 4, indicating a physical interaction between PSDP and PI3K in activated neutrophils. Moreover, PSDP (0.4-800 pmol) directly inhibited recombinant human p110γ-PI3K activity. During an experimental model of lung injury and inflammation, a reciprocal relationship was also present in vivo for lung PSDP and PI3K activity. To investigate its therapeutic potential, we developed a new PSDP structural mimetic that blocked human neutrophil activation and mouse lung PI3K activity and inflammation. Together, our findings indicate that PSDP is an endogenous PI3K inhibitor, and suggest that in inflammatory diseases characterized by excessive neutrophil activation, PIPPs can serve as structural templates in a novel antineutrophil therapeutic strategy to limit tissue injury.

UR - http://www.scopus.com/inward/record.url?scp=33645856488&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645856488&partnerID=8YFLogxK

U2 - 10.1084/jem.20052143

DO - 10.1084/jem.20052143

M3 - Article

C2 - 16567384

AN - SCOPUS:33645856488

VL - 203

SP - 857

EP - 863

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 4

ER -